Comparing the Efficacy and Safety of Vericiguat With Standard Medical Treatment in Heart Failure Patients

NCT07697833 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)

Interventions

DRUG: Vericiguat tablet
DRUG: Placebo

Sponsor

National Institute of Cardiovascular Diseases, Pakistan

Collaborators

[object Object]